
23andMe Struggles as Sequoia Capital Sells Shares
- Genetics-testing company 23andMe's value has dropped by a third as former investors, including Sequoia Capital, sell shares.
- The company is fighting for survival amid doubts over its business model and concerns over its genetic data...
